A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss

Clinical trial NCT00333229 · TERMINATED

Trial details

NCT number: NCT00333229
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women

Start date: 2006-03-01
Primary completion: 2013-12-01
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.